tavaborole

  • Low <em>In Vitro</em> Antifungal Activity of Tavaborole against Yeasts and Molds from Onychomycosis
    Susceptibility
    Low In Vitro Antifungal Activity of Tavaborole against Yeasts and Molds from Onychomycosis

    The in vitro activity of tavaborole, an FDA-approved antifungal drug, was compared to that of four antifungal agents against 170 clinical fungal isolates originating from patients with onychomycosis. Tavaborole had low activity against all isolates compared to itraconazole, terbinafine, and fluconazole, the principal choices for treatment of onychomycosis.

    Mahdi Abastabar, Iman Haghani, Tahereh Shokohi, Mohammad Taghi Hedayati, Seyed Reza Aghili, Ali Jedi, Sulmaz Dadashi, Shafigheh Shabanzadeh, Tahereh Hosseini, Narges Aslani, Jacques F. Meis, Hamid Badali
Back to top